MSB11022 in Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT03052322 · COMPLETED

Trial details

NCT number: NCT03052322
Sponsor: Fresenius Kabi SwissBioSim GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Rheumatoid Arthritis

Start date: 2017-01-31
Primary completion: 2018-05-28
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.